A new consumer data set projects that Canadian cannabis consumers will spend over C$1,600 a year on cannabis products by 2025.

On Tuesday (March 26), research and business firm EY announced that the average Canadian cannabis consumer’s spending on cannabis products will increase 30 percent by 2025.

The study is projecting an increase from C$1,263 annually from consumers in 2019 to C$1,652 by 2025.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

The data indicates that the overall Canadian cannabis market will grow by 50 percent to reach C$11 billion in 2025.

EY projects that the supply of cannabis will top demand within the next five years.

According to the firm, if this prediction comes true, the average cost of wholesale dried flower will decrease to between C$4 and C$5.

In February, The GrowthOp reported on the average price of dried marijuana for each province in Canada.

In arguing against the notion that increasing costs for legal marijuana products pushes consumers towards the illicit market, Zachary Pendley, EY Canada cannabis real estate and valuation leader, said the consumer trend is due to the slower-than-expected rollout for retail.

“As the industry matures, access to product eases and higher margin derivatives come online, we’ll see a rise in consumer spending on legal cannabis,” Pendley said in a press release.

On the road to the legalization of recreational marijuana in October 2018, provinces were tasked with setting up retail models.

However, the process wasn’t smooth for every area, with Ontario and BC conducting slower rollouts for the markets. Ontario is still set to open its privatized retail market starting April 1, with some shops opening their doors later.

The study also projects that, by the year 2025, 20 percent of the total adult population will be cannabis consumers.

In addition, it indicates how consumption trends for different types of products are set to change.

Consumption splits from EY show dried flower will command a leading 46-percent market share, with extracts securing 37-percent of the market by 2025.

Edibles will only obtain a 12-percent share, and non-edible derivatives placed last with a 5-percent market share. Both are scheduled to become legal in Canada on or before October 17, 2019.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less